Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk.
Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A, Swerdlow A, Thorne H; KConFab Investigators; Riboli E, Vineis P, Dorronsoro M, Clavel-Chapelon F, Panico S, Onland-Moret NC, Trichopoulos D, Kaaks R, Khaw KT, Brown R, Flanagan JM.
Brennan K, et al. Among authors: swerdlow a.
Cancer Res. 2012 May 1;72(9):2304-13. doi: 10.1158/0008-5472.CAN-11-3157. Epub 2012 Feb 28.
Cancer Res. 2012.
PMID: 22374981
Free article.